Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- Starting dose: 240 mg SC (two 120 mg injections, 40 mg/mL each)
- Maintenance dose: 80 mg SC (single injection, 20 mg/mL) every 28 days, starting 28 days after starting dose
- Route: Subcutaneous only (abdominal region); avoid areas under waistband or ribs
- Must be administered by a healthcare professional
- EU also approves use as neo-adjuvant/adjuvant with radiotherapy